SomaLogic, Inc., Boulder, Colorado, USA.
Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, Colorado, USA.
J Clin Microbiol. 2017 Oct;55(10):3072-3088. doi: 10.1128/JCM.00469-17. Epub 2017 Aug 9.
Direct pathogen detection in blood to diagnose active tuberculosis (TB) has been difficult due to low levels of circulating antigens or due to the lack of specific, high-affinity binding reagents and reliable assays with adequate sensitivity. We sought to determine whether slow off-rate modified aptamer (SOMAmer) reagents with subnanomolar affinity for proteins (antigens 85A, 85B, 85C, GroES, GroEL2, DnaK, CFP10, KAD, CFP2, RplL, and Tpx) could be useful to diagnose tuberculosis. When incorporated into the multiplexed, array-based proteomic SOMAscan assay, limits of detection reached the subpicomolar range in 40% serum. Binding to native proteins was confirmed by using culture filtrate proteins and fractions from infected macrophages and via affinity capture assays and subsequent mass spectrometry. Comparison of serum from culture-positive pulmonary TB patients and TB suspects systematically ruled out for TB revealed small but statistically significant ( < 0.0001) differences in the median signals and in specific pathogen markers, such as antigen 85B. Samples where many aptamers produced high signals were rare exceptions. In concentrated, protein-normalized urine from TB patients and non-TB controls, the CFP10 (EsxB) SOMAmer yielded the most significant differential signals ( < 0.0276), particularly in TB patients with HIV coinfection. In conclusion, direct antigen detection proved difficult even with a sensitive method such as SOMAscan, likely due to their very low, subpicomolar abundance. The observed differences between cases and controls had limited diagnostic utility in serum and urine, but further evaluation of SOMAmers using other platforms and sample types is warranted.
由于循环抗原水平低,或缺乏特异性、高亲和力的结合试剂和具有足够灵敏度的可靠检测方法,直接从血液中检测病原体以诊断活动性结核病 (TB) 一直存在困难。我们试图确定对 蛋白(抗原 85A、85B、85C、GroES、GroEL2、DnaK、CFP10、KAD、CFP2、RplL 和 Tpx)具有亚纳摩尔亲和力的慢洗脱修饰适体 (SOMAmer) 试剂是否可用于诊断结核病。当将这些试剂整合到基于多重阵列的蛋白质组学 SOMAscan 检测中时,检测限在 40%的血清中达到亚皮摩尔范围。通过使用培养滤液蛋白和感染巨噬细胞的馏分,以及通过亲和捕获测定和随后的质谱法,证实了与天然 蛋白的结合。对培养阳性的肺结核患者和经过系统排除结核病的疑似结核病患者的血清进行比较,发现中位 信号和特定病原体标志物(如抗原 85B)存在微小但具有统计学意义的差异(<0.0001)。产生高信号的许多 适体的样本是罕见的例外。在结核患者和非结核对照的浓缩、蛋白归一化尿液中,CFP10(EsxB)SOMAmer 产生了最显著的差异信号(<0.0276),尤其是在合并 HIV 感染的结核患者中。总之,即使使用 SOMAscan 等敏感方法,直接检测 抗原也证明很困难,这可能是由于其非常低的亚皮摩尔丰度所致。病例与对照之间的差异在血清和尿液中具有有限的诊断效用,但需要进一步使用其他平台和样本类型评估 适体。